Wesche Holger

Chief Scientific Officer at Harpoon Therapeutics, Inc.

Sold, on record
$1.1M
Dollars the filings state
Form 4 sales
9
Latest Jul 1, 2021
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale Harpoon Therapeutics, Inc.Plan not stated
    Apr 28, 2020 2020

    Sold 1,250 shares at $14.05 ($18k)

    Wesche Holger, Chief Scientific Officer

    Sold 2.3% of holdings ($758k position)52,669 shares leftFiling

  2. 2 Form 4 sale Harpoon Therapeutics, Inc.Plan not stated
    May 11, 2020 +13 days

    Sold 7,350 shares at $14.10 ($104k)

    Wesche Holger, Chief Scientific Officer

    Sold 12.2% of holdings ($847k position)52,669 shares leftFiling

  3. 3 Form 4 sale Harpoon Therapeutics, Inc.Plan not stated
    May 12, 2020 +1 day

    Sold 1,400 shares at $14.09 ($20k)

    Wesche Holger, Chief Scientific Officer

    Sold 2.6% of holdings ($762k position)52,669 shares left0.2x usual sizeFiling

  4. 4 Form 4 sale Harpoon Therapeutics, Inc.Plan not stated
    Jul 1, 2020 +50 days

    Sold 10,000 shares at $16.20 ($162k)

    Wesche Holger, Chief Scientific Officer

    Sold 16% of holdings ($1M position)52,669 shares left2.3x usual sizeFiling

  5. 5 Form 4 sale Harpoon Therapeutics, Inc.Plan not stated
    Oct 1, 2020 +92 days

    Sold 10,000 shares at $16.27 ($163k)

    Wesche Holger, Chief Scientific Officer

    Sold 16% of holdings ($1M position)52,669 shares left1.4x usual sizeFiling

  6. 6 Form 4 sale Harpoon Therapeutics, Inc.Plan not stated
    Jan 4, 2021 +95 days

    Sold 10,000 shares at $18.38 ($184k)

    Wesche Holger, Chief Scientific Officer

    Sold 15.9% of holdings ($1.2M position)52,852 shares left1.2x usual sizeFiling

  7. 7 Form 4 sale Harpoon Therapeutics, Inc.Plan not stated
    Apr 1, 2021 +87 days

    Sold 10,000 shares at $20.45 ($204k)

    Wesche Holger, Chief Scientific Officer

    Sold 15.9% of holdings ($1.3M position)52,852 shares left1x usual sizeFiling

  8. 8 Form 4 sale Harpoon Therapeutics, Inc.Plan not stated
    Jul 1, 2021 +91 days

    Sold 10,000 shares at $14.00 ($140k)

    Wesche Holger, Chief Scientific Officer

    Sold 15.9% of holdings ($880k position)52,852 shares left1x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (9)

Form 144 notices and Form 4 sales by Wesche Holger
Source
Jul 1, 2021Jul 6, 2021Harpoon Therapeutics, Inc.Chief Scientific OfficerForm 4 sale10,000$140k15.9%Plan not statedSEC
Apr 1, 2021Apr 5, 2021Harpoon Therapeutics, Inc.Chief Scientific OfficerForm 4 sale10,000$204k15.9%Plan not statedSEC
Jan 4, 2021Jan 6, 2021Harpoon Therapeutics, Inc.Chief Scientific OfficerForm 4 sale10,000$184k15.9%Plan not statedSEC
Oct 1, 2020Oct 5, 2020Harpoon Therapeutics, Inc.Chief Scientific OfficerForm 4 sale10,000$163k16.0%Plan not statedSEC
Jul 1, 2020Jul 2, 2020Harpoon Therapeutics, Inc.Chief Scientific OfficerForm 4 sale10,000$162k16.0%Plan not statedSEC
May 12, 2020May 13, 2020Harpoon Therapeutics, Inc.Chief Scientific OfficerForm 4 sale1,400$20k2.6%Plan not statedSEC
May 11, 2020May 11, 2020Harpoon Therapeutics, Inc.Chief Scientific OfficerForm 4 sale7,350$104k12.2%Plan not statedSEC
Apr 28, 2020Apr 30, 2020Harpoon Therapeutics, Inc.Chief Scientific OfficerForm 4 sale1,250$18k2.3%Plan not statedSEC
Jan 2, 2020Jan 6, 2020Harpoon Therapeutics, Inc.Chief Scientific OfficerForm 4 sale10,000$144k16.0%Plan not statedSEC